IOL Chemicals and Pharmaceuticals Limited

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

15-10-2025 | 03:36 pm

IOLCP secured an EDQM Certificate of Suitability for its Pantoprazole Sodium Sesquihydrate Process-III API. This key approval opens the door for supplying this drug ingredient to the European market, indicating potential business expansion and future revenue opportunities.

PDF

No comments yet. Be the first to comment!

All announcements from IOL Chemicals and Pharmaceuticals Limited

Download our app

IOL Chemicals and Pharmaceuticals Limited — Important, 15-10-2025: Updates

IOL Chemicals and Pharmaceuticals Limited

Updates